Literature DB >> 19754217

Progress towards therapeutic application of RNA interference for HIV infection.

Sunit K Singh1, Rajesh K Gaur.   

Abstract

HIV-1 infection is the cause of acquired immune deficiency syndrome (AIDS). Highly active antiretroviral therapy (HAART) has been successful in reducing the rate of progression to AIDS, but a cure has not yet been achieved. New tools are required to delay progression of infection or to block the replication cycle of HIV. RNA interference (RNAi) has the potential to work as a powerful tool against HIV infection. The mode of action of small interfering RNAs (siRNAs) against their target genes is through sequence complementarity, which in turn results in target degradation. siRNAs are showing enormous potential to be used as a therapeutic tool in various diseases; however, this technology still requires refinement before its full potential can be utilized for the development of HIV therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754217     DOI: 10.2165/11317120-000000000-00000

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  7 in total

Review 1.  Current progress in the development of RNAi-based therapeutics for HIV-1.

Authors:  J Zhou; J J Rossi
Journal:  Gene Ther       Date:  2011-09-29       Impact factor: 5.250

Review 2.  Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.

Authors:  Jiehua Zhou; John Rossi
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

Review 3.  Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.

Authors:  Jiehua Zhou; John J Rossi
Journal:  BioDrugs       Date:  2012-12-01       Impact factor: 5.807

4.  Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.

Authors:  Jiehua Zhou; C Preston Neff; Piotr Swiderski; Haitang Li; David D Smith; Tawfik Aboellail; Leila Remling-Mulder; Ramesh Akkina; John J Rossi
Journal:  Mol Ther       Date:  2012-11-20       Impact factor: 11.454

5.  RNA interference approaches for treatment of HIV-1 infection.

Authors:  Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Genome Med       Date:  2015-05-28       Impact factor: 11.117

Review 6.  Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy.

Authors:  Roland Schwarzer; Andrea Gramatica; Warner C Greene
Journal:  Viruses       Date:  2020-02-08       Impact factor: 5.048

7.  RNAi induces innate immunity through multiple cellular signaling pathways.

Authors:  Zhongji Meng; Xiaoyong Zhang; Jun Wu; Rongjuan Pei; Yang Xu; Dongliang Yang; Michael Roggendorf; Mengji Lu
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.